Exact Mass: 416.0168428
Exact Mass Matches: 416.0168428
Found 86 metabolites which its exact mass value is equals to given mass value 416.0168428,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-[(4-{[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}-2-methylphenyl)methyl]-1,3-thiazolidine-2,4-dione
1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)-
C15H17IN2O2S (416.00554520000003)
Perfluoro-2-butyltetrahydrofuran
Flucofuron
CONFIDENCE Identification confirmed with Reference Standard (Level 1); Source 414_9616_msms.txt
mollicellin M
A member of the class of depsidones that is 3,4-dihydro-2H,7H-chromeno[7,6-b][1,4]benzodioxepine substituted by a chloro group at position 9, a hydroxy group at position 10, methyl groups at positions 2, 2, 5 and 8, a formyl group at position 11 and oxo groups at positions 4 and 7. Isolated from Chaetomium brasiliense it exhibits antimalarial and cytotoxic activities.
(2S)-N-[(E)-2-(2,4-dibromo-5-methoxyphenyl)ethenyl]-1-methyl-2-pyrrolidinecarboxamide|amathamide A
clionastatin B
C19H16Cl4O2 (415.99043559999996)
An androstanoid that is androsta-3,5,8,16-tetraene substituted by chloro groups at positions 1, 2, 16 and 19 and oxo groups at positions 7 and 15 (the 1beta,2alpha stereoisomer). It is isolated from burrowing sponge Cliona nigricans and exhibits cytotoxic efficacy.
CAY10597
3,5-dichloro-2-(2,4-dihydroxy-6-methoxycarbonylphenoxy)-6-methoxy-4-methylbenzoic acid
3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoic acid
Geodin Hydrate
EUK-134
N-PROPYL-3-METHYLPYRIDINIUM BIS(TRIFLUOROMETHYLSULFONYL)IMIDE
C11H14F6N2O4S2 (416.02991560000004)
disodium 2-[(1-hydroxy-4-sulphonato-2-naphthyl)azo]benzoate
C17H10N2Na2O6S (416.00549600000005)
sodium 5-chloro-3-[(1,5-dihydroxy-2-naphthyl)azo]-2-hydroxybenzenesulphonate
C16H10ClN2NaO6S (415.98457900000005)
N-(6-Iodo-2-(trimethylsilyl)furo[3,2-b]pyridin-7-yl)pivalamide
C15H21IN2O2Si (416.04169959999996)
1H-Pyrrolo[2,3-b]pyridine, 3-bromo-5-(1-Methyl-1H-pyrazol-4-yl)-1-(phenylsulfonyl)-
7-(6-bromohexoxy)-5-hydroxy-2-phenylchromen-4-one
C21H21BrO4 (416.06231260000004)
6-[[4-(2,5-Dihydro-2,5-Dioxo-1H-Pyrrol-1-Yl)Phenyl]Amino]-2-Naphthalenesulfonicacid Sodium Salt(1:1)
C20H13N2NaO5S (416.04428480000007)
meso-ethylenebis(1-indenyl)zirconium(iv) dichloride
C20H16Cl2Zr (415.96760759999995)
1-Butylpyridinium bis[(trifluoromethyl)sulfonyl]azanide
C11H14F6N2O4S2 (416.02991560000004)
2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile
C18H17BrN4O3 (416.04839519999996)
2-methyl-2-[4-[(3,4,5-trichlorophenyl)carbamoylamino]phenoxy]propanoic acid
C17H15Cl3N2O4 (416.00973600000003)
3-[5-(3-nitrobenzoyl)-1,3-dioxoisoindol-2-yl]benzoic acid
Ethylenediaminetetraacetic acid tetrasodium salt dihydrate
C10H16N2Na4O10 (416.03957160000004)
rac-Ethylenebis(2-methyl-1-indenyl)zirconium dichloride
C20H16Cl2Zr (415.96760759999995)
Benzenesulfonothioicacid, 4-methyl-, S1,S1-1,3-propanediyl ester
Crolibulin
C18H17BrN4O3 (416.04839519999996)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)-
C15H17IN2O2S (416.00554520000003)
D004791 - Enzyme Inhibitors
2-[5-[(3,4-Dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
2-[[3-(4-methylphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]-N-(2-thiazolyl)acetamide
2-[5-[(2,4-Dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine
3,5-Dichloro-2-(2,4-dihydroxy-6-methoxycarbonylphenoxy)-6-methoxy-4-methylbenzoic acid
disodium 2-hydroxy-5-[(E)-(6-sulfonato-2-naphthyl)diazenyl]benzoate
C17H10N2Na2O6S (416.00549600000005)
(1S,2S,10S,13S,14R)-1,2,16-trichloro-10-(chloromethyl)-13-methyl-2,11,12,14-tetrahydro-1H-cyclopenta[a]phenanthrene-7,15-dione
C19H16Cl4O2 (415.99043559999996)
3-[(2Z)-2-(3-ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)-1,3-benzothiazol-3-yl]propane-1-sulfonic acid
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-(4-fluorophenyl)sulfonylprop-2-enenitrile
N-[5-[2-(4-chloroanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-furancarboxamide
4-[[2-[(2E)-2-[(Z)-2-chloro-3-(4-nitrophenyl)prop-2-enylidene]hydrazinyl]-2-oxoacetyl]amino]benzoic acid
C18H13ClN4O6 (416.05235880000004)
2-[(E)-3-oxo-3-phenylprop-1-enyl]sulfanyl-6-thiophen-2-yl-4-(trifluoromethyl)pyridine-3-carbonitrile
C20H11F3N2OS2 (416.02648719999996)
[2,6-Dihydroxy-4-(3,5,6,7-tetrahydroxy-4-oxo-2,3-dihydrochromen-2-yl)phenyl] hydrogen sulate
C15H12O12S (416.00494720000006)
[5,6,7-Trihydroxy-4-oxo-2-(2,3,4-trihydroxyphenyl)-2,3-dihydrochromen-3-yl] hydrogen sulate
C15H12O12S (416.00494720000006)
5-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3-hydroxy-4-sulooxycyclohexene-1-carboxylic acid
C16H16O11S (416.04133060000004)
2-[(3E)-3-[(5Z)-5-[(6-bromo-1H-indol-3-yl)methylidene]-3,6-dioxopiperazin-2-ylidene]propyl]guanidine
C17H17BrN6O2 (416.05962819999996)
BAY-1797
C20H17ClN2O4S (416.05975120000005)
BAY-1797 is a potent, orally active, and selective P2X4 antagonist, with an IC50 of 211 nM against human P2X4. BAY-1797 displays no or very weak activity on the other P2X ion channels. BAY-1797 shows anti-nociceptive and anti-inflammatory effects[1].
(1r,4r,5r,6r,7s,8r)-6-(acetyloxy)-7-amino-4-hydroxy-4-(c-hydroxycarbonimidoyl)-8-(phosphonooxy)-9-oxa-3-thiabicyclo[3.3.1]nonane-1-carboxylic acid
C11H17N2O11PS (416.02906620000005)
6-(acetyloxy)-7-amino-4-hydroxy-4-(c-hydroxycarbonimidoyl)-8-(phosphonooxy)-9-oxa-3-thiabicyclo[3.3.1]nonane-1-carboxylic acid
C11H17N2O11PS (416.02906620000005)
2,8,9-trichloro-9a-(chloromethyl)-11a-methyl-3ah,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3,4-dione
C19H16Cl4O2 (415.99043559999996)
5-bromo-2-{[(1s,3r)-3-bromo-2,2-dimethyl-6-methylidenecyclohexyl]methyl}-4-methoxyphenol
C17H22Br2O2 (415.99864319999995)
6-chloro-5-hydroxy-7,12,16,16-tetramethyl-9,14-dioxo-2,10,17-trioxatetracyclo[9.8.0.0³,⁸.0¹³,¹⁸]nonadeca-1(19),3,5,7,11,13(18)-hexaene-4-carbaldehyde
n-[(1e)-2-(2,4-dibromo-5-methoxyphenyl)ethenyl]-1-methylpyrrolidine-2-carboximidic acid
(2s)-n-[(1e)-2-(2,4-dibromo-5-methoxyphenyl)ethenyl]-1-methylpyrrolidine-2-carboximidic acid
(2s)-n-[(1z)-2-(2,4-dibromo-5-methoxyphenyl)ethenyl]-1-methylpyrrolidine-2-carboximidic acid
5-bromo-2-[(3-bromo-2,2-dimethyl-6-methylidenecyclohexyl)methyl]-4-methoxyphenol
C17H22Br2O2 (415.99864319999995)
n-[2-(2,4-dibromo-5-methoxyphenyl)ethenyl]-1-methylpyrrolidine-2-carboximidic acid
methyl 14,16-dibromohexadeca-7,13,15-trien-5-ynoate
C17H22Br2O2 (415.99864319999995)
methyl (7e,13e,15z)-14,16-dibromohexadeca-7,13,15-trien-5-ynoate
C17H22Br2O2 (415.99864319999995)